Lamictal

Quick links to important sections

Lamictal

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lamictal

Property Description
Active ingredient Lamotrigine
Form Tablet (immediate-release, chewable, extended-release)
Pharmacological class Anticonvulsant (AED), Mood Stabilizer
General purpose Controlling neuronal excitability
Origin Synthetic, Phenyltriazine derivative

Lamictal: The Definition and Pharmacological Classification

Lamictal is a prescription-only medication whose sole active ingredient is Lamotrigine. The medicine is primarily classified as an Anticonvulsant, recognized as an Antiepileptic Drug (AED). Lamotrigine is also designated as a Mood Stabilizer for specific maintenance therapy. This compound is chemically a synthetic drug, identified as a Phenyltriazine derivative.

Clinical evidence indicates Lamotrigine's Mood Stabilizer classification, demonstrating its efficacy in promoting neurological stability over extended periods. The medicine's fundamental purpose, therefore, is to regulate and stabilize abnormal electrical signals within the brain, which is a recognized treatment strategy for chronic conditions involving neural instability.

Composition, Origin, and Available Forms (Lamotrigine)

The product is a single-ingredient product (monocomponent), containing only Lamotrigine as the active substance. The required route of administration for all available forms is oral (by mouth).

Lamotrigine is made available in several distinct dosage forms for patient flexibility. These include the standard immediate-release tablet, a chewable dispersible tablet which is beneficial for patients who have difficulty swallowing, and a specialized extended-release tablet. The extended-release tablet is engineered to provide a prolonged, consistent delivery of Lamotrigine over an extended period, optimizing absorption kinetics.

How Lamictal Functions: Stabilization of Neural Membranes

The function of Lamotrigine centers on achieving equilibrium by regulating neuronal excitability within the central nervous system. Its core mechanism involves modulating the electrical activity of nerve cells. The compound acts by binding to and inhibiting voltage-gated sodium channels, thereby reducing the rapid electrical firing of neurons. This action also minimizes the release of excitatory chemical messengers such as glutamate and aspartate. This comprehensive control provides the general benefit necessary for an Antiepileptic Agent in promoting neural balance.

Regulatory References

  1. Lamotrigine - StatPearls - NCBI Bookshelf

What side effects are possible with Lamictal?

Possible side effects and safety information

The official safety profile for Lamotrigine, as documented in government regulatory sources, defines potential adverse effects by frequency and the body system affected. These classifications distinguish between frequently reported, non-serious effects and specific, rare, but clinically important reactions.

Frequency-Classified Adverse Reactions

Side effects are categorized by the regulatory body based on their incidence in clinical data:

  • Very Common (Affects 10% or more): Dizziness, Headache, Ataxia (lack of coordination), Somnolence (drowsiness), Diplopia (double vision), Nausea, Vomiting, and Rash.
  • Common (Affects 1% to 10%): Insomnia, Tremor, Diarrhea, Abdominal pain, Dry mouth, Pharyngitis, and Fatigue.

Serious Adverse Reactions and Key Safety Patterns

The regulatory labeling explicitly documents rare, serious adverse reactions that require specific attention. These include potentially life-threatening severe skin rashes, such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and other multiorgan hypersensitivity reactions. Documented serious risks also involve Blood Dyscrasias and the potential for increased Suicidal Behavior and Ideation.

Most cases of serious rash have been reported to occur within the first two to eight weeks of treatment initiation. The risk is explicitly noted to be increased by exceeding the recommended initial dose or recommended rate of dose escalation. Specific safety considerations for pediatric patients include a higher documented incidence rate of serious rashes compared to adults. Dosage adjustments are also required for patients with moderate-to-severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Lamotrigine overdose identifies specific manifestations and life-threatening outcomes that necessitate immediate medical attention.

Overdose presentations typically involve disturbances of the Central Nervous System (CNS), including ataxia (unsteady gait), nystagmus (involuntary eye movement), and impaired consciousness, which can escalate to recurrent seizures and coma.

Acritical risk documented is severe cardiovascular toxicity, including signs of cardiac conduction delays, wide complex tachycardia (WCT), and cardiac arrest; fatalities have been reported with large acute ingestions and high serum concentrations (e.g., greater than 25 mg/L in adults). Specific risk factors for toxicity differ: pediatric patients (under 3.5 years old) may be more susceptible to CNS effects, while severe cardiac issues are primarily reported in adults.

Due to the severity of these documented outcomes, regulatory guidance explicitly states that a patient with suspected or confirmed overdose should be admitted to the hospital immediately to receive appropriate supportive therapy. Management is procedural and symptomatic, driven by the officially recognized need to address both CNS and cardiac effects. While no specific antidote is known, supportive measures may involve gastrointestinal decontamination (e.g., activated charcoal or gastric lavage). Continuous monitoring of cardiac conduction is required to manage the potential for life-threatening heart rhythm disturbances.

Therapeutic Uses of Lamictal

What Lamictal Treats: Main Uses and Benefits

This medication is used to assist with managing and reducing the frequency and intensity of various types of seizures. It is commonly used in conditions characterized by periods of heightened symptoms such as epilepsy, and for the long-term management of Bipolar I Disorder. It is relevant for easing the impact of symptoms that create noticeable physiological strain, assisting with delaying the time to recurrence of manic, hypomanic, and depressive episodes.

Managing Symptoms of Recurrent Seizure Activity

The medication helps manage symptoms related to increased neurological or muscular activity, including types of seizures that affect specific areas of the brain or the entire body. It provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during symptomatic periods. It is relevant for managing symptoms that interfere with daily comfort.

Supporting Functional Stability in Mood Disorders

This medication is applied when groups of symptoms appear suddenly or fluctuate, such as episodic mood swings in Bipolar I Disorder. By addressing symptoms related to systemic imbalance, it may assist with maintaining functional stability and supports the patient during difficult episodes by easing distress.


Quick Fact: It is commonly used to help with managing symptoms in conditions involving episodic or fluctuating manifestations like epilepsy and bipolar disorder.

Eligibility and Restrictions for Use

Lamictal (lamotrigine) is subject to specific population eligibility rules defined by government regulatory bodies based on age, current health status, and other limiting conditions.

Contraindications and Age Limitations

  • Absolute Contraindication: The drug must not be used by patients with a known hypersensitivity or allergy to lamotrigine or any of its ingredients.
  • Pediatric Use: The medication is approved for adjunctive seizure therapy in children aged 2 years and older. Safety and effectiveness have not been established in children younger than 2 years of age.
  • Bipolar Use: Use for the maintenance treatment of Bipolar I Disorder is approved only for adults aged 18 years and older.
  • Acute Mood Episodes: Lamictal is not recommended for the acute treatment of manic or mixed episodes, as effectiveness has not been established for this purpose.

Conditions Requiring Restricted Use

Population/Condition Regulatory Status (Requirement)
History of Serious Rash Restarting treatment is generally not recommended unless the potential benefits significantly outweigh the risks.
Moderate to Severe Hepatic Impairment Requires dose adjustments (reduction) in the initial, escalation, and maintenance phases.
Significant Renal Impairment Reduced maintenance doses may be effective; caution is advised due to limited chronic treatment experience in this population.
Pregnancy/Lactation Lamotrigine passes into breast milk and may cause fetal harm based on animal data. Use requires careful monitoring of the infant and weighing of risks versus benefits.

What should I know about interactions with other medicines?

Lamictal (lamotrigine) interacts with various medicines, which can change its effectiveness or increase the risk of side effects. It is critical to inform your healthcare provider about all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are taking.

Major Drug Interactions

Certain medications significantly alter the concentration of lamotrigine in the body, often requiring dosage adjustments:

  • Other Antiepileptic Drugs:

    • Valproate (valproic acid, divalproex sodium): Can more than double lamotrigine levels, greatly increasing the risk of a serious rash. Lamotrigine's starting dose is often halved when taken with valproate.
    • Carbamazepine, Phenytoin, Phenobarbital, Primidone: These can decrease lamotrigine concentrations by approximately 40%, potentially reducing its effectiveness. A higher maintenance dose of lamotrigine is typically needed.
  • Hormonal Contraceptives: Estrogen-containing oral contraceptives and hormone replacement therapy can decrease lamotrigine blood levels by about 50%, which may lessen seizure control or mood stabilization. This interaction can also potentially reduce the effectiveness of the contraceptive.

  • Antibiotics and Antivirals: The antibiotic Rifampin and certain HIV protease inhibitors (e.g., lopinavir/ritonavir, atazanavir/ritonavir) can lower lamotrigine levels, possibly making it less effective.

Other Considerations

  • Alcohol: Consumption of alcohol while taking Lamictal may intensify central nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. It is generally advised to limit or avoid alcohol use.
  • Herbal and Dietary Products: Certain supplements may also influence lamotrigine levels. Always discuss the use of herbal remedies, vitamins, and other dietary products with your doctor.

Mechanism of Action

Primary Molecular Target: Voltage-Sensitive Sodium Channels

Lamictal's mechanism of action involves modulating the electrical activity within the central nervous system. It achieves this modulation by preferentially inhibiting voltage-sensitive sodium channels on presynaptic neuronal membranes. This action is thought to occur through binding to the inactive state of the channel.

Mechanistic Cascade and Neurotransmitter Modulation

Inhibition of sodium channels decreases the overall excitability of the neuronal membrane, which, in turn, decreases the release of excitatory neurotransmitters, primarily glutamate and aspartate, from the presynaptic terminals. By modulating membrane excitability, Lamictal modulates neuronal firing frequency. It also modulates the high rates of calcium influx that are typically associated with excessive neuronal firing. The combined effect of these interactions results in a modulated signaling environment within the central nervous system.

Dosage and Administration Information

Lamotrigine, the active ingredient in Lamictal, is administered exclusively via the oral route. The medication is available in several forms, including standard immediate-release tablets, chewable dispersible tablets, and extended-release (XR) tablets, which are engineered for once-daily use.

The core principle of lamotrigine administration is the titration schedule, which involves initiation at a low starting dose followed by gradual escalation over several weeks to reach the long-term target dose. This protocol establishes the maintenance dose range, which typically falls between 100 mg and 500 mg daily for immediate-release formulations. The speed of the dose escalation and the final dose are dependent on the patient's concomitant medication regimen, such as the use of enzyme-inducing or enzyme-inhibiting drugs.

Immediate-release tablets are generally taken once or twice per day and may be administered with or without food. Specialized administration conditions exist for certain forms: extended-release tablets must be swallowed whole and must not be crushed, chewed, or divided. If the medication is stopped for an extended period, reinitiation involves restarting the original low-dose titration schedule. Furthermore, dose reductions are required for patients with moderate to severe hepatic impairment and may be needed in cases of significant renal impairment. The use of the drug typically follows a long-term continuation pattern and requires a stepwise reduction (tapering) over at least two weeks if discontinuation is required.

Recent Clinical Evidence

Lamotrigine (Lamictal) is an anticonvulsant medication that has been studied extensively for its role in both epilepsy and bipolar I disorder. It functions primarily by stabilizing neuronal membranes, an effect thought to be achieved by inhibiting voltage-sensitive sodium channels and modulating the release of excitatory neurotransmitters like glutamate.

Bipolar Disorder: Maintenance

Clinical trials support lamotrigine's use in the maintenance treatment of Bipolar I disorder. Evidence from large-scale, placebo-controlled studies indicates that the drug helps delay the time to recurrence of mood episodes, particularly depressive episodes. It is generally not considered effective for the acute treatment of manic or mixed episodes.

Efficacy Area Primary Research Findings
Depressive Episodes (Prevention) Studies indicate reduced risk of depressive recurrence in patients with Bipolar I disorder.
Acute Depression (Treatment) Findings are mixed, with limited evidence supporting its efficacy in the acute phase of bipolar depression compared to placebo.
Acute Mania/Mixed Episodes The drug has not demonstrated consistent efficacy for treating acute manic or mixed episodes.

Epilepsy and Seizures

Lamotrigine is established as an effective treatment for several types of seizures, including partial-onset seizures, primary generalized tonic-clonic seizures, and generalized seizures associated with Lennox-Gastaut syndrome. It is used both as monotherapy and as adjunctive therapy in patients aged two years and older. Recent research continues to examine its efficacy in monotherapy and adjunctive regimens for drug-resistant epilepsies. A gradual dose escalation is required at initiation to mitigate the risk of serious rash, including Stevens-Johnson syndrome.

Frequently Asked Questions (FAQ)

Common questions about Lamictal (FAQ)

Q: What is the 'Lamictal rash' and how serious is it?

Lamotrigine has been linked to a risk of very serious, life-threatening skin reactions, including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Official warnings state that the risk is highest during the first two months of treatment and is increased if the initial dose is too high or increased too quickly.

Q: Can Lamictal cause changes in weight?

According to the official product information, weight change is generally not listed among the most commonly reported side effects in the clinical trials for Lamotrigine. However, as with any medication, concerns regarding weight changes or other effects can be addressed with a healthcare provider.

Q: Is it normal to feel drowsy or dizzy when starting Lamictal?

Yes, regulatory documents list dizziness and drowsiness (somnolence) as very common side effects. These effects were reported by 10% or more of patients during clinical trials. Patients are generally advised to exercise caution when starting or adjusting this medication.

Q: Does Lamictal affect sleep patterns?

Official information indicates that Lamotrigine can affect sleep patterns. Insomnia (difficulty sleeping) is a common side effect, and dream abnormality has also been reported in some patients during post-marketing experience.

Q: Can you drink alcohol in moderation while on Lamictal?

Regulatory guidance suggests that consuming alcohol while taking Lamotrigine may intensify central nervous system side effects such as increased dizziness, drowsiness, and difficulty concentrating. Regulatory warnings state that it is generally recommended to limit or avoid alcohol use.

Q: Is Lamictal safe to take during pregnancy?

Lamotrigine should only be used during pregnancy if the potential benefit is determined to justify the potential risks to the developing fetus. Official guidance advises using the lowest effective dose. Clinical guidelines suggest that patients who become pregnant while taking this medicine may be encouraged to consider enrolling in pregnancy registries for monitoring.

Q: Does Lamictal have an effect on birth control pills?

Yes, a significant interaction exists: estrogen-containing oral contraceptives can substantially lower the levels of Lamotrigine in the body, which may reduce its effectiveness. Conversely, Lamotrigine may also reduce the effectiveness of the contraceptive itself, and dose adjustments or alternative methods may be topics for discussion with a prescriber.

Q: Can Lamictal make anxiety worse when first starting?

The official side effect tables do not list anxiety among the most common adverse reactions. However, related central nervous system effects like agitation and insomnia have been reported. Any changes in mood or anxiety levels should be reported to a healthcare provider.

Q: What are the long-term effects of taking Lamictal?

Official regulatory warnings highlight potential long-term safety considerations, which include the risk of rare but serious reactions such as multiorgan hypersensitivity (DRESS), certain blood disorders, and the potential for increased suicidal thoughts or behavior. Recent warnings also mention a risk of cardiac rhythm problems in patients with pre-existing heart conditions.

Q: Can men taking Lamictal have fertility concerns?

While the regulatory label does not strictly contraindicate use in men, one study mentioned a potential effect on fertility. However, other regulatory-cited studies found no effect on key parameters like sperm count or motility. Concerns regarding fertility can be discussed with a healthcare professional.

Q: Can Lamictal cause hair loss?

Hair loss (alopecia) is not listed as a very common or common side effect based on initial clinical trials. However, it is an effect that has been reported in post-marketing experience by people taking the drug.

Q: What is the typical maintenance dose range for Lamictal in bipolar disorder?

Regulatory information describes a target maintenance dose for Bipolar I Disorder, which is then individualized based on what other medicines the patient is taking. For instance, the required dose may be lower or higher depending on whether the concurrent medications slow down or speed up the clearance of Lamotrigine from the body.

Q: How often do I need blood work while taking Lamictal?

Official documents note that Lamotrigine may rarely cause blood disorders and that patients should be monitored for signs of such problems. However, the regulatory information does not specify a routine, mandatory blood testing schedule for all patients.

Q: Does Lamictal affect memory or concentration?

The official adverse reaction list includes effects like drowsiness, dizziness, and lack of coordination (ataxia) that can impact a patient's alertness and focus. The regulatory warnings also emphasize the need to monitor for changes in thinking or behavior.

Q: Is it safe to drive or operate machinery while adjusting to Lamictal?

Official product information advises caution. Because Lamotrigine can cause dizziness, drowsiness, and vision problems, regulatory guidance suggests that individuals should avoid driving or operating complex machinery until they understand how the medication affects their physical and mental abilities.

Q: Are generic versions of Lamictal (lamotrigine) as effective as the brand name?

Generic lamotrigine products are approved by regulatory agencies, provided they meet strict bioequivalence standards. This means the generic product must deliver the same amount of the active ingredient to the bloodstream over the same period of time as the brand-name drug.

Q: Why do some people experience initial headaches when starting this medication?

Headache is listed as a very common side effect reported in clinical trials. In rare cases, the FDA has also warned that Lamotrigine can be associated with aseptic meningitis, a serious reaction characterized by severe headache, typically occurring early in treatment.

Q: Is Lamictal known to cause any long-term kidney or liver problems?

Regulatory warnings for rare, serious immune reactions, such as DRESS, note that these conditions can involve significant organ damage, including issues with the liver and kidneys. Dose adjustments are also required for patients who already have pre-existing liver or kidney impairment.

Q: Does taking Lamictal increase sensitivity to the sun?

Official post-marketing reports have documented cases of photosensitivity reactions in some patients taking Lamotrigine. This indicates that the drug may potentially cause a skin reaction upon exposure to sunlight or UV light.

Q: Are there any reported interactions between Lamictal and herbal supplements?

Official regulatory guidance advises patients to always inform their doctor or pharmacist about all supplements, vitamins, and herbal remedies they are taking. This is because these products may potentially influence the blood levels of Lamotrigine.

Q: What percentage of people experience significant side effects on Lamictal?

The frequency of side effects is classified by official bodies. For example, the most common effects like dizziness and headache are listed as very common, meaning they affect 10% or more of patients. Conversely, the risk of a life-threatening rash is rare, estimated at about 1 in 1,000 for adults.

Q: Why is it important to report a fever or swollen glands when on this drug?

Fever, rash, and swollen lymph nodes may be the initial symptoms of serious, potentially fatal reactions like DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) or HLH (Hemophagocytic Lymphohistiocytosis). These symptoms warrant immediate reporting to a healthcare provider for medical evaluation.

Q: Can Lamictal cause strange or vivid dreams?

Dream abnormality is an adverse event that has been reported by a small percentage of patients in clinical trials. It is a known potential effect of the medication.

Q: What is the connection between Lamictal and Steven Johnson Syndrome (SJS)?

Stevens-Johnson syndrome (SJS) is a rare, severe allergic-type reaction involving the skin and mucous membranes. It is explicitly linked to the use of Lamotrigine, and this risk is the main reason for the mandatory slow dose escalation schedule.

Q: Is Lamictal safe for people with a history of heart issues?

Official regulatory warnings note that Lamotrigine may increase the risk of serious, life-threatening arrhythmias (heart rhythm problems). This risk is primarily for patients with pre-existing heart disorders, such as heart failure or valvular heart disease. A careful assessment of potential benefits versus risks is part of the prescribing decision for these patients.

Q: Is Lamictal used for conditions other than bipolar disorder and epilepsy?

The drug is officially approved only for the maintenance treatment of Bipolar I disorder and for various types of seizures associated with epilepsy. Use for any other condition is considered outside of its approved indications.

How should Lamictal be stored and disposed of?

Storage Requirements

Lamictal (lamotrigine) tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be kept in the original container and be protected from light and moisture to maintain stability.

Storage Classification Requirement
Temperature Range 20 C to 25 C (Excursions up to 30 C)
Environmental Rule Protect from Light and Moisture
Child Safety Rule Keep out of the reach and sight of children

Disposal Instructions

Regulatory guidelines prohibit discarding unused or expired Lamictal in household trash or down the sink/toilet (wastewater). Disposal must adhere to local environmental and public health requirements.

Patients should use an authorized medicine take-back program if one is available in their area. Otherwise, unused product disposal must follow the specific local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lamictal found in:

A-Z Index: